Published in Gene Therapy Weekly, January 29th, 2004
Robert Humphreys, MD, PhD, executive VP and chief scientific officer of Antigen Express, delivered the presentation in a poster that illustrated the benefits of using Antigen Express's proprietary and patented Ii protein antisense reagents to induce a T helper cell response to prostate cancer antigens.
The therapy cured about half of the mice with an aggressive, poorly...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.